Eun-Ryeong Hahm

13PUBLICATIONS
18CO-AUTHORS
Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 04, 2026
Oral Administration of Withaferin A Increases Infiltration of CD4+ Helper T Cells in a Mouse Model of Mammary Tumor.

|Mar 19, 2026
Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer.

Eun-Ryeong Hahm, Bruce L Jacobs, Krishna B Singh

|Feb 25, 2026
Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax® on Fatty Acid Synthesis in Prostate Cancer.

Eun-Ryeong Hahm, Bruce L Jacobs, Krishna B Singh

|Nov 03, 2023
Mechanism of synergistic inhibitory effect of benzyl isothiocyanate and zoledronic acid combination on breast cancer induction of osteoclast differentiation.

Eun-Ryeong Hahm, Su-Hyeong Kim, Subrata K Pore

|Jun 02, 2023
Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells.

Su-Hyeong Kim, Eun-Ryeong Hahm, Shivendra V Singh

|Apr 17, 2023
Withaferin A inhibits breast cancer-induced osteoclast differentiation.

Eun-Ryeong Hahm, Su-Hyeong Kim, Shivendra V Singh

Pageof 3

Frequent Collaborators

13 joint publications

Shivendra V Singh

6 joint publications

Su-Hyeong Kim

5 joint publications

Krishna B Singh

2 joint publications

Rajiv Dhir